Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Terminated1
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

terminated133%
unknown133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
completed

Development of a Microbiome Non-invasive Diagnosis Tool

NCT03330444
terminated

Diagnosis of Chronic Endometritis in Endometrial Fluid Using Molecular Techniques to Improve the Outcomes of Assisted Reproductive Treatments

NCT03169621
unknownnot_applicable

Quantitative Identification of Implantation Receptivity by Single Cell Transcriptome Analysis

NCT03091023

Clinical Trials (3)

Showing 3 of 3 trials
NCT03330444

Development of a Microbiome Non-invasive Diagnosis Tool

Completed
NCT03169621

Diagnosis of Chronic Endometritis in Endometrial Fluid Using Molecular Techniques to Improve the Outcomes of Assisted Reproductive Treatments

Terminated
NCT03091023Not Applicable

Quantitative Identification of Implantation Receptivity by Single Cell Transcriptome Analysis

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3